Centric Ultra Orphan Conference 2009 | Agenda

print Printable PDF

General Information | Monday 8.24 | Tuesday 8.25 | Wednesday 8.26

General Information

Sponsor:	Centric Health Resources
Media Partner:	Pharmaceutical Executive Magazine
Date:	Monday, August 24, 2009 Welcome Reception 6:00 - 8:00 p.m. Home Nightclub Tuesday, August 25, 2009 8:00 a.m. - 4:15 p.m. Day 1 of Program 4:15 - 5:15 p.m. Wine & Cheese Reception 5:00 p.m. Free Time. Group event: Buses will leave at 6:00 p.m. for the Cardinals baseball game. Please indicate your interest in attending at registration. Other on-your-own activities in the area include the Ameristar Casino, Old St. Charles, The Winery of the Little Hills, a jogging/bike trail, and other hotel/casino events. Wednesday, August 26, 2009 8:00 a.m. – 12:00 noon Day 2 of Program
Location:	Ameristar Casino One Ameristar Boulevard St. Charles, MO 63301 Located 10 minutes from Lambert St. Louis Airport (airport shuttles available)
Accommodations:	Call the Ameristar Casino (636-940-4300) and ask for the Centric Conference Rate, or make reservations online at http://www.ameristar.com/corp/index.asp.
Fees:	There is no charge for this event. Participants are responsible for their own travel, hotel, and incidentals.
Dress Code:	Business Casual.
RSVP:	Call 866-849-4481 or Click here to register. Seating is limited. Please make your reservations early.
Who Should Attend:	Industry professionals with interest in ultra-orphan diseases: Industry Consultants Biotech Companies Specialty Pharmaceutical Companies Venture Capital Companies Patient Advocacy Groups Health Plans, Employers and other Benefits Managers
About the Sponsors:	Centric Health Resources is a nationwide organization serving the specialized needs of individuals with certain rare and chronic disorders, along with their families, specialist physicians, and healthcare payers. As a specialty pharmacy employing patient centered health management services, Centric works with patient advocacy organizations, pharmaceutical companies, biotech firms and managed care organizations to deliver prescribed therapies and specialized health services. Other sponsors to be announced.

Welcome Reception Monday, August 24, 2009

6:00 p.m. - 8:00 p.m. Welcome Reception, Ameristar Casino, Home Nightclub

Main Program - Tuesday, August 25 2009

8:00 a.m.	Registration and continental breakfast
8:30 a.m.	Opening Remarks
9:00 a.m.	Keynote Speaker - The Good News for Biotech The new regulatory model favors highly active medicines for small patient populations Call it the "biotech" model - or call it the "orphan" model: it is selling medicines patient by patient, with very "high touch" Sponsors who embrace the logic of the new model should find it advantageous Economics appear to us to strongly favor smaller companies over larger Examples Michael McCaughan, Elsevier Business Intelligence
9:45 a.m.	Break
10:15 a.m.	Biotech Commentary on the “High Touch” Model - Panel Discussion Is the high-touch model sustainable? Can we really implement personalized medicine? What are the major hurdles in the near term? Longer term? Will innovation continue in the U.S.? Invited speaker - Larry Stern, CEO Talecris Biotherapeutics Invited speaker - William Sullivan, Specialty Pharmacy Consulting Accepted speaker - Anthony Bonelli, A. Bonelli Consulting and former CEO, Hemispherx Biopharma Invited speaker - TBA Invited speaker - TBA
11:00 a.m.	Regulatory/REMS/Health Intelligence 18 month review of the FDA and REMS Approval hurdles and ways to mitigate Recommendations Accepted speaker – David A. Galardi, Pharm.D., Apogenics
11:45 p.m.	Lunch
12:30 p.m.	The New Administration and the Impact on Orphan Drug Development Recent healthcare plan developments and predictions The good and the bad for orphan drugs What patient advocacy is doing about it and how companies can participate Impact of biosimilars, if any NORD initiatives, concerns, and priorities. Jayson Slotnik, Hogan & Hartson, LLP, Washington, D.C. Diane Edquist Dorman, National Organization for Rare Disorders (NORD)
1:15 p.m.	Reimbursement Trends Pay for performance Value-based benefit design Comparative Effectiveness Dennis Matheis, President, Anthem Blue Cross and Blue Shield of Missouri
2:00 p.m.	Break
2:15 p.m.	Payer Access and Contracting Gain expert assessment on SP's ability to manage the medical benefit What are the implications for orphan and ultra orphan therapies? Hear the skills that are needed to manage reimbursement for small patient populations Oral solid vs. injectible – key payer considerations Effectiveness of LOAs Jim Long, Principal, BioSolutia Dean Erhardt, MBA, Principal, D2 Pharma Consulting, LLC David Galardi, PharmD, Apogenics
3:00 p.m.	Viewpoints on Health Management – Panel Discussion This session will discuss ideas around: Case study – Alpha-1 study Advocacy Involvement The importance of individual learning styles Providing data to support pay for performance Dr. Robert (Sandy) Sandhaus – Medical Director, AlphaNet John Walsh, Chairman of the Board, Centric Health Resources; President, CEO, and co-founder, The Alpha-1 Foundation Dr. David Sirois, DMD, PhD, Chairman of the Board of Directors, The International Pemphigus & Pemphigoid Foundation> Dr. Warwick Charlton, M.D., MBA, Chief Medical Officer, Centric Health Resources, Inc.
4:00 p.m.	Virtual Tour
4:15 p.m.	Wine & Cheese Reception
5:00 p.m.	Bus leaves for ballpark, other local events are on your own.

Main Program - Wednesday, August 26, 2009

8:00 a.m.	Continental Breakfast
8:30 a.m.	Summary of Day 1 and Preview of Day 2
8:45 a.m.	Integrating REMS Requirements with Distribution Getting to market faster Impacting patient compliance Meeting the needs of physicians Providing data to support pay for performance Craig Kephart, President & CEO, Centric Health Resources, Inc.
9:30 a.m.	Using Social Networking to Find Patients and Grow Your Market Social Networking Primer Case Study Applications in Health Managment Wendy White, Founder and President, Siren Interactive
10:15 a.m.	Break
10:45 a.m.	Include Distribution and Patient Services in Pricing Build pricing models to obtain the right price Include cost of distribution Include cost of REMS Factor in increased risk What else to include, why, and how Douglas Paul, Vice President and Partner, MME Consultants
11:30 a.m.	Review Goals of the Session
11:45 a.m.	Evaluations
12:00 p.m.	Close of Session

St. Louis attractions

Click here to register

August 24-26, 2009
Ameristar Casino
St. Louis, MO

There is no charge for this event.
Seating is limited, so register early!

Hotel Accommodations Available at Ameristar. Reserve Your Room Now